Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases
Abstract Background Smoking is a major risk factor of cardiovascular diseases, notably peripheral arterial disease (PAD). Despite this link, research on smoking cessation interventions in PAD patients remains scarce and inconclusive regarding the efficacy of such interventions. Therefore, elucidatin...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-024-20192-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850254035879198720 |
|---|---|
| author | Sebastian Scheliga Mara Derissen Knut Kröger Rainer Röhrig Lea Schomacher Hannah Schick Rainer Beckers Hinrich Böhner Ute Habel |
| author_facet | Sebastian Scheliga Mara Derissen Knut Kröger Rainer Röhrig Lea Schomacher Hannah Schick Rainer Beckers Hinrich Böhner Ute Habel |
| author_sort | Sebastian Scheliga |
| collection | DOAJ |
| description | Abstract Background Smoking is a major risk factor of cardiovascular diseases, notably peripheral arterial disease (PAD). Despite this link, research on smoking cessation interventions in PAD patients remains scarce and inconclusive regarding the efficacy of such interventions. Therefore, elucidating it is crucial and should address both individuals who smoke that are motivated to quit and individuals who smoke heavily lacking the motivation to quit. Methods/Design The Aachen Smoking Cessation and Harm Reduction (ASCHR) trial is a prospective randomized controlled study (RCT) on the benefits of telemedical-psychological support for smoking cessation in patients with PAD, funded by the “Innovation Fund” of the Joint Federal Committee in Germany. This trial aims to scientifically assess the efficacy, feasibility, acceptance, and efficiency of a multi-stage smoking cessation program based on the recommendations of the German guideline for smoking cessation tailored to patients with PAD, compared to a control group receiving no intervention. Central to the program is psychological counseling utilizing motivational interviewing techniques, delivered through telemedicine via video consultations. The primary endpoint of the ASCHR trial is the smoking cessation rate after 8 months of intervention, with a secondary endpoint evaluating sustained abstinence at a further 6 months follow-up. Smoking cessation is defined as a carbon monoxide level in exhaled air of less than 6 ppm. We hypothesize that the group receiving the multi-stage cessation program will yield a cessation rate at least 10 percentage points higher than that of usual care. Anticipating a dropout rate of around 35%, the planned sample size is at least N = 1032 study participants. Discussion Should the trial demonstrate significant positive outcomes, efforts should be made to integrate the program into routine care in Germany, potentially offering a promising base for future smoking cessation support among PAD patients. |
| format | Article |
| id | doaj-art-63b4eeaf8a314b398bbddf59e0ccfb06 |
| institution | OA Journals |
| issn | 1471-2458 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj-art-63b4eeaf8a314b398bbddf59e0ccfb062025-08-20T01:57:13ZengBMCBMC Public Health1471-24582024-10-012411910.1186/s12889-024-20192-7Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseasesSebastian Scheliga0Mara Derissen1Knut Kröger2Rainer Röhrig3Lea Schomacher4Hannah Schick5Rainer Beckers6Hinrich Böhner7Ute Habel8Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen UniversityDepartment of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen UniversityClinic for Vascular Medicine, Klinik Für Angiologie, HELIOS Klinik KrefeldInstitute for Medical Informatics, RWTH Aachen UniversityZTG Center for Telematics and Telemedicine GmbHZTG Center for Telematics and Telemedicine GmbHZTG Center for Telematics and Telemedicine GmbHDepartment of General and Visceral Surgery, Catholic Hospital Dortmund WestDepartment of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen UniversityAbstract Background Smoking is a major risk factor of cardiovascular diseases, notably peripheral arterial disease (PAD). Despite this link, research on smoking cessation interventions in PAD patients remains scarce and inconclusive regarding the efficacy of such interventions. Therefore, elucidating it is crucial and should address both individuals who smoke that are motivated to quit and individuals who smoke heavily lacking the motivation to quit. Methods/Design The Aachen Smoking Cessation and Harm Reduction (ASCHR) trial is a prospective randomized controlled study (RCT) on the benefits of telemedical-psychological support for smoking cessation in patients with PAD, funded by the “Innovation Fund” of the Joint Federal Committee in Germany. This trial aims to scientifically assess the efficacy, feasibility, acceptance, and efficiency of a multi-stage smoking cessation program based on the recommendations of the German guideline for smoking cessation tailored to patients with PAD, compared to a control group receiving no intervention. Central to the program is psychological counseling utilizing motivational interviewing techniques, delivered through telemedicine via video consultations. The primary endpoint of the ASCHR trial is the smoking cessation rate after 8 months of intervention, with a secondary endpoint evaluating sustained abstinence at a further 6 months follow-up. Smoking cessation is defined as a carbon monoxide level in exhaled air of less than 6 ppm. We hypothesize that the group receiving the multi-stage cessation program will yield a cessation rate at least 10 percentage points higher than that of usual care. Anticipating a dropout rate of around 35%, the planned sample size is at least N = 1032 study participants. Discussion Should the trial demonstrate significant positive outcomes, efforts should be made to integrate the program into routine care in Germany, potentially offering a promising base for future smoking cessation support among PAD patients.https://doi.org/10.1186/s12889-024-20192-7Smoking cessationPeripheral arterial diseaseTelemedicinePsychological support |
| spellingShingle | Sebastian Scheliga Mara Derissen Knut Kröger Rainer Röhrig Lea Schomacher Hannah Schick Rainer Beckers Hinrich Böhner Ute Habel Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases BMC Public Health Smoking cessation Peripheral arterial disease Telemedicine Psychological support |
| title | Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases |
| title_full | Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases |
| title_fullStr | Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases |
| title_full_unstemmed | Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases |
| title_short | Aachen smoking cessation and harm reduction (ASCHR) trial study protocol – scientific evaluation of a psychological-telemedical counseling concept for smoking cessation in patients with vascular diseases |
| title_sort | aachen smoking cessation and harm reduction aschr trial study protocol scientific evaluation of a psychological telemedical counseling concept for smoking cessation in patients with vascular diseases |
| topic | Smoking cessation Peripheral arterial disease Telemedicine Psychological support |
| url | https://doi.org/10.1186/s12889-024-20192-7 |
| work_keys_str_mv | AT sebastianscheliga aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT maraderissen aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT knutkroger aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT rainerrohrig aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT leaschomacher aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT hannahschick aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT rainerbeckers aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT hinrichbohner aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases AT utehabel aachensmokingcessationandharmreductionaschrtrialstudyprotocolscientificevaluationofapsychologicaltelemedicalcounselingconceptforsmokingcessationinpatientswithvasculardiseases |